| Q34500921 | 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis |
| Q57245378 | 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis |
| Q90354326 | A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis - results of clinical relevance |
| Q83366916 | A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases |
| Q36181347 | A comparison of time dependent Cox regression, pooled logistic regression and cross sectional pooling with simulations and an application to the Framingham Heart Study. |
| Q50783103 | A longitudinal study of the influence of smoking on the onset of obesity at a telecommunications company in Japan. |
| Q47230688 | A longitudinal study on the effect of shift work on weight gain in male Japanese workers |
| Q43861352 | A nationwide population-based retrospective cohort study: increased risk of acute coronary syndrome in patients with ankylosing spondylitis |
| Q36449974 | A pilot study on short term heart rate variability & its correlation with disease activity in Indian patients with rheumatoid arthritis. |
| Q53121954 | A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome. |
| Q58484343 | A study on vascular endothelial growth factor and endothelin-1 in patients with extra-articular involvement of rheumatoid arthritis |
| Q35139150 | A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study |
| Q37785123 | AJC Editor's Consensus: Selective and Nonselective Nonsteroidal Anti-Inflammatory Drugs and Cardiovascular Risk |
| Q88348165 | Abatacept for Treatment of Rheumatoid Arthritis: Special Focus on the Elderly |
| Q37533319 | Abatacept therapy and safety management |
| Q52587395 | Absence of Fibrosis and Inflammation by Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients with Low to Moderate Disease Activity. |
| Q35932689 | Accelerated atherosclerosis in inflammatory rheumatic diseases |
| Q36951047 | Accelerated atherosclerosis in rheumatoid arthritis |
| Q90446908 | Accelerated immunosenescence in rheumatoid arthritis: impact on clinical progression |
| Q44712212 | Acute and long-term effect of infliximab on humoral and echocardiographic parameters in patients with chronic inflammatory diseases |
| Q37690126 | Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis |
| Q90478695 | Adjunctive Chinese Herbal Products Therapy Reduces the Risk of Ischemic Stroke Among Patients With Rheumatoid Arthritis |
| Q38751610 | Adverse Events During Anti-TNFα Therapies in IBD (Excluding Infections and Malignancies): When to Stop, Continue, or Switch Therapies |
| Q40309503 | Albuminuria in Rheumatoid Arthritis: Associations with RA Characteristics and Subclinical Atherosclerosis |
| Q37402723 | Alterations to the middle cerebral artery of the hypertensive-arthritic rat model potentiates intracerebral hemorrhage. |
| Q33304235 | Aminotransferases are associated with insulin resistance and atherosclerosis in rheumatoid arthritis |
| Q42699610 | An Overview of the Extraarticular Involvement in Rheumatoid Arthritis and its Management |
| Q46640190 | An atypical case of typical chest pain |
| Q37856782 | Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience. |
| Q51104000 | Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study. |
| Q38857820 | Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review |
| Q24673716 | Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety |
| Q35637080 | Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis |
| Q36554649 | Apolipoprotein B-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis |
| Q37331767 | Aspirin use in rheumatoid arthritis patients with increased risk of cardiovascular disease |
| Q28212591 | Aspirin, NSAIDs, and COX-2 inhibitors in cardiovascular disease: possible interactions and implications for treatment of rheumatoid arthritis |
| Q64251395 | Assessment of Cardiovascular Disease Risk and Therapeutic Patterns among Urban Black Rheumatoid Arthritis Patients |
| Q34346209 | Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study |
| Q37169541 | Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid Arthritis. |
| Q39502759 | Association between antiphospholipid antibodies and arterial thrombosis in patients with rheumatoid arthritis |
| Q89970218 | Association between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry |
| Q55043697 | Association between inflammation and systolic blood pressure in RA compared to patients without RA. |
| Q47772043 | Association between metabolic syndrome, BMI, and serum vitamin D concentrations in rheumatoid arthritis |
| Q33650548 | Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients |
| Q40556385 | Association of Anti-Citrullinated Peptide Antibodies With Coronary Artery Calcification in Rheumatoid Arthritis |
| Q41550162 | Association of Nocturnal Hypertension With Disease Activity in Rheumatoid Arthritis |
| Q36640598 | Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial |
| Q36633139 | Association of circulating levels of MMP-8 with mortality from respiratory disease in patients with rheumatoid arthritis. |
| Q37179297 | Association of epicardial adipose tissue with cardiometabolic risk and metabolic syndrome in patients with rheumatoid arthritis |
| Q47885394 | Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term followup from disease onset. |
| Q35541874 | Association of paraoxonase 1 gene polymorphism and enzyme activity with carotid plaque in rheumatoid arthritis. |
| Q37358225 | Association of periodontitis with rheumatoid arthritis and atherosclerosis: Novel paradigms in etiopathogeneses and management? |
| Q92466356 | Associations of Handgrip Strength with Prevalence of Rheumatoid Arthritis and Diabetes Mellitus in Older Adults |
| Q58691455 | Asthma is associated with carotid arterial injury in children: The Childhood Origins of Asthma (COAST) Cohort |
| Q35637447 | Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis |
| Q35110147 | Asymptomatic atherosclerosis in egyptian rheumatoid arthritis patients and its relation to disease activity |
| Q36596894 | Atherogenic lipid profiles and its management in patients with rheumatoid arthritis |
| Q36594764 | Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression |
| Q36726386 | Atherosclerosis and inflammation: insights from rheumatoid arthritis |
| Q36253671 | Atherosclerosis and rheumatoid arthritis: more than a simple association |
| Q88898639 | Atherosclerosis assessment and rheumatoid arthritis |
| Q27010113 | Atherosclerosis in juvenile idiopathic arthritis |
| Q35553376 | Atherosclerotic cardiovascular disease in rheumatoid arthritis |
| Q38365624 | Atherosclerotic vascular disease in the autoimmune rheumatologic patient |
| Q52372999 | Atherosclerotic vascular disease in the autoimmune rheumatologic woman. |
| Q87858477 | Atorvastatin effect on systemic lupus erythematosus disease activity: a double-blind randomized clinical trial |
| Q35554200 | Autoantibodies and thrombophilia in RA: TNFalpha and TNFalpha blockers |
| Q33686087 | Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis |
| Q38494303 | Behaviour change interventions to promote physical activity in rheumatoid arthritis: a systematic review. |
| Q34591298 | Benefits of exercise in rheumatoid arthritis |
| Q38096206 | Biological therapies for rheumatoid arthritis: progress to date |
| Q38293735 | Biomarkers for cardiovascular risk assessment in autoimmune diseases |
| Q24816784 | Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis |
| Q33442034 | Biomarkers of oxidant stress, insulin sensitivity and endothelial activation in rheumatoid arthritis: a cross-sectional study of their association with accelerated atherosclerosis |
| Q92462247 | Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis |
| Q37307297 | Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis |
| Q38098110 | Biventricular thrombus and associated myocardial infarction in a rheumatoid arthritis patient: a case report and literature review |
| Q36154527 | Body composition in patients with rheumatoid arthritis is not different than healthy subjects |
| Q88599465 | Can we predict thrombotic tendency in rheumatoid arthritis? A thromboelastographic analysis (with ROTEM) |
| Q38876331 | Cardiac Impairment in Rheumatoid Arthritis and Influence of Anti-TNFα Treatment. |
| Q36355415 | Cardiac manifestations of rheumatological conditions: a narrative review |
| Q27008927 | Cardiorheumatology: cardiac involvement in systemic rheumatic disease |
| Q63683454 | Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease-Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction? |
| Q54255528 | Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients. |
| Q38937245 | Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study |
| Q35554980 | Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s |
| Q58609925 | Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis |
| Q47098082 | Cardiovascular autonomic regulation, inflammation and pain in rheumatoid arthritis |
| Q28168900 | Cardiovascular care and cancer screening in female nurses with and without rheumatoid arthritis |
| Q92464675 | Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment |
| Q36835851 | Cardiovascular co-morbidity in rheumatic diseases |
| Q89136015 | Cardiovascular comorbidities of rheumatoid arthritis in Taiwanese adults: A retrospective single-center study |
| Q38568465 | Cardiovascular comorbidity in rheumatic diseases |
| Q26823443 | Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure |
| Q36218375 | Cardiovascular disease and rheumatoid arthritis: an update |
| Q35121150 | Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions |
| Q38950371 | Cardiovascular disease in patients with rheumatoid arthritis |
| Q36757060 | Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study |
| Q34495257 | Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america |
| Q21195262 | Cardiovascular disease in systemic sclerosis--an emerging association? |
| Q37688153 | Cardiovascular disease is preventable among women |
| Q37859676 | Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity |
| Q43622317 | Cardiovascular events and survival in rheumatoid arthritis: effects of anti-tumor necrosis factor-alpha treatment |
| Q35617716 | Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q36283434 | Cardiovascular involvement in rheumatoid arthritis |
| Q33806651 | Cardiovascular morbidity and mortality in rheumatoid arthritis |
| Q26739070 | Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers |
| Q33859039 | Cardiovascular risk factors predate the onset of symptoms of rheumatoid arthritis: a nested case-control study |
| Q99240510 | Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout |
| Q38813397 | Cardiovascular risk in patients with rheumatoid arthritis |
| Q82835412 | Cardiovascular risk in patients with rheumatoid arthritis: assessment of several traditional risk parameters and a German risk score model |
| Q36361147 | Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs |
| Q37142052 | Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs |
| Q34563216 | Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment |
| Q44960512 | Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications |
| Q37055056 | Cardiovascular risk score in Rheumatoid Arthritis |
| Q37956137 | Cardiovascular safety of biologic therapies for the treatment of RA. |
| Q37422931 | Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study |
| Q37796382 | Carotid Intima Media Thickness in Rheumatoid Arthritis as Compared to Control Subjects: A Meta-Analysis |
| Q35777047 | Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis |
| Q51312219 | Carotid enlargement and serum levels of von Willebrand factor in rheumatoid arthritis: a follow-up study. |
| Q58545718 | Central role of RIPK1-VDAC1 pathway on cardiac impairment in a non-human primate model of rheumatoid arthritis |
| Q34354276 | Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases |
| Q26774158 | Chronic Inflammatory Diseases and Endothelial Dysfunction |
| Q46259292 | Chronic inflammatory autoimmune disorders and atherosclerosis |
| Q36809874 | Circulating endothelial progenitor cells as a link between synovial vascularity and cardiovascular mortality in rheumatoid arthritis |
| Q55383962 | Citrullination as a plausible link to periodontitis, rheumatoid arthritis, atherosclerosis and Alzheimer’s disease. |
| Q33562858 | Co-Occurrence of Arthritis and Stroke amongst Middle-Aged and Older Adults in Canada |
| Q38059460 | Coagulation and the fibrin network in rheumatic disease: a role beyond haemostasis |
| Q81525215 | Combination of the C1429T polymorphism in the G-protein beta-3 subunit gene and the A1330V polymorphism in the low-density lipoprotein receptor-related protein 5 gene is a risk factor for hypercholesterolaemia |
| Q33579891 | Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey |
| Q49788530 | Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study |
| Q47116867 | Comparative Risk of Cardiovascular Outcomes Between Topical and Oral Nonselective NSAIDs in Taiwanese Patients With Rheumatoid Arthritis |
| Q40961450 | Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis |
| Q39020908 | Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis |
| Q89278102 | Comparison of statin eligibility according to the Adult Treatment Panel III, ACC/AHA blood cholesterol guideline, and presence of carotid plaque by ultrasound in Mexican mestizo patients with rheumatoid arthritis |
| Q34316084 | Comparison of symptoms, treatment, and outcomes of coronary artery disease among rheumatoid arthritis and matched subjects undergoing percutaneous coronary intervention |
| Q36220832 | Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study. |
| Q36253978 | Contractile, but not endothelial, dysfunction in early inflammatory arthritis: a possible role for matrix metalloproteinase-9 |
| Q49493173 | Coronary Artery Inflammation in Rheumatoid Arthritis Using Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography |
| Q38749160 | Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases |
| Q35557952 | Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease |
| Q36486905 | Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs |
| Q34389625 | Cutaneous markers of coronary artery disease |
| Q30990764 | Data-driven identification of co-morbidities associated with rheumatoid arthritis in a large US health plan claims database |
| Q47747454 | Depression and anxiety symptoms as predictors of mortality in PCI patients at 10 years of follow-up |
| Q41728784 | Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study |
| Q36898455 | Determination of the diagnostic values of asymmetric dimethylarginine as an indicator for evaluation of the endothelial dysfunction in patients with rheumatoid arthritis |
| Q37859679 | Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease |
| Q81489115 | Diastolic heart function in RA patients |
| Q84286730 | Dietary alpha lipoic acid supplementation prevents synovial inflammation and bone destruction in collagen-induced arthritic mice |
| Q35655764 | Disease activity in rheumatoid arthritis and the risk of cardiovascular events |
| Q41521795 | Disease duration of rheumatoid arthritis is a predictor of vascular stiffness: a cross-sectional study in patients without known cardiovascular comorbidities: A STROBE-compliant article |
| Q36573102 | Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study |
| Q35605663 | Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study |
| Q79487694 | Do antirheumatic drugs increase the risk of acute myocardial infarction? |
| Q80167150 | Do tumor-necrosis-factor inhibitors prevent first cardiovascular events in patients with rheumatoid arthritis? |
| Q33682822 | Double-stranded DNA induces a prothrombotic phenotype in the vascular endothelium. |
| Q37521891 | ECG non-specific ST-T and QTc abnormalities in patients with systemic lupus erythematosus compared with rheumatoid arthritis |
| Q43524523 | Editorial: inflammation, disease-modifying antirheumatic drugs, lipids, and cardiovascular risk in rheumatoid arthritis |
| Q47862098 | Educational website incorporating rheumatoid arthritis patient needs for Latin American and Caribbean countries. |
| Q40959053 | Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein-Enriched Serum in Rheumatoid Arthritis |
| Q43663319 | Effect of HIV duration on ambulatory blood pressure in HIV-infected individuals with high office blood pressure |
| Q45158519 | Effect of body mass index on mortality and clinical status in rheumatoid arthritis |
| Q45184227 | Effect of glucocorticoids on the arteries in rheumatoid arthritis |
| Q34530587 | Effect of high-intensity statin treatment in rheumatoid arthritis: a case with possible coronary atheroma regression and progression of rheumatoid valve degeneration |
| Q87641476 | Effect of hypertension on echocardiographic parameters in rheumatoid arthritis |
| Q44204800 | Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease |
| Q87586879 | Effect of methotrexate use and erythrocyte methotrexate polyglutamate on glycosylated hemoglobin in rheumatoid arthritis |
| Q36843049 | Effect of rheumatoid factor on mortality and coronary heart disease |
| Q38323310 | Effects of TNFα inhibitors on adiposity and other cardiovascular risk factors: implications for the cardiovascular prognosis in patients with rheumatoid arthritis |
| Q64906378 | Elucidating the endogenous synovial fluid proteome and peptidome of inflammatory arthritis using label-free mass spectrometry. |
| Q89967683 | Enalapril Influence on Arterial Stiffness in Rheumatoid Arthritis Women: A Randomized Clinical Trial |
| Q87621947 | Epicardial adipose tissue thickness, flow-mediated dilatation of the brachial artery, and carotid intima-media thickness: Associations in rheumatoid arthritis patients |
| Q34986307 | Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. |
| Q37883018 | Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. |
| Q37930979 | Ethnic differences in cardiovascular risk in rheumatic disease: focus on Asians |
| Q35166773 | Etoricoxib for arthritis and pain management |
| Q43832641 | Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? |
| Q38098647 | Examining the risk of cardiovascular disease in patients with psoriasis: a critical review. |
| Q88915778 | Exercise is Associated With Increased Small HDL Particle Concentration and Decreased Vascular Stiffness in Rheumatoid Arthritis |
| Q34238357 | Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity |
| Q35154792 | Extra-articular Manifestations in Rheumatoid Arthritis. |
| Q83205796 | Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis |
| Q36702061 | Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis |
| Q55172246 | Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis. |
| Q40062767 | Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis |
| Q37132910 | First time myocardial infarction in a rheumatic patient after elective arthroplasty |
| Q33841419 | Future therapeutic targets in rheumatoid arthritis? |
| Q51780235 | G-protein beta3 subunit variant C825T is a risk factor for hypertension in Japanese females--a prospective cohort study over 5 years. |
| Q47571604 | Gender and cardiovascular disease: are sex-biased microRNA networks a driving force behind heart failure with preserved ejection fraction in women? |
| Q37283020 | Genomics and proteomics: a new approach for assessing thrombotic risk in autoimmune diseases. |
| Q53653844 | Glucocorticoid use is associated with increase in HDL and no change in other lipids in rheumatoid arthritis patients. |
| Q34185602 | Gluten-free diet in nonceliac disease |
| Q36757006 | Gluten-free vegan diet induces decreased LDL and oxidized LDL levels and raised atheroprotective natural antibodies against phosphorylcholine in patients with rheumatoid arthritis: a randomized study. |
| Q42617646 | GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk |
| Q27016011 | HIV and aging: emerging research issues |
| Q47408388 | High Expression of STAT3 in Subcutaneous Adipose Tissue Associates with Cardiovascular Risk in Women with Rheumatoid Arthritis |
| Q38719851 | High titer of anti-citrullinated peptide antibody is a risk factor for severe carotid atherosclerotic plaque in patients with rheumatoid arthritis: the TOMORROW study |
| Q36245981 | High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study |
| Q44804684 | High-dose atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of statins. |
| Q28480869 | High-sensitivity cardiac troponin-I is elevated in patients with rheumatoid arthritis, independent of cardiovascular risk factors and inflammation |
| Q37672346 | Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis |
| Q39473004 | Hospitalizations for Acute Myocardial Infarction Are Decreased Among Patients with Inflammatory Bowel Disease Using a Nationwide Inpatient Database. |
| Q36877859 | Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients |
| Q36246086 | Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals |
| Q34114277 | Hyperuricemia and incident cardiovascular disease and noncardiac vascular events in patients with rheumatoid arthritis |
| Q24242787 | Hypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritis |
| Q37980338 | Hypoxia--a key regulator of angiogenesis and inflammation in rheumatoid arthritis |
| Q30515381 | IL-17 and TNF-α sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation |
| Q58160099 | Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study |
| Q92122504 | Immunotherapy for the rheumatoid arthritis-associated coronary artery disease: promise and future |
| Q35637252 | Impact of parental history on patients' cardiovascular mortality in rheumatoid arthritis |
| Q92355252 | Impaired renal functions in Pakistani cohort of rheumatoid arthritis |
| Q44485195 | Implication of antithrombotic agents on potential bleeding from endoscopically determined peptic ulcers, incidentally detected as surrogate markers for nsaids-associated ulcers complication |
| Q37058794 | Important issues at heart: cardiovascular risk management in rheumatoid arthritis |
| Q46337002 | Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis |
| Q100476604 | Incidence of congestive heart failure in rheumatoid arthritis: a review of literature and meta-regression analysis |
| Q99711818 | Incident arterial vascular events in a cohort of Puerto Ricans with rheumatoid arthritis |
| Q90466112 | Increase in serum triglyceride was associated with coronary plaque vulnerability in a patient with rheumatoid arthritis |
| Q35213557 | Increased 30-day and 1-year mortality rates and lower coronary revascularisation rates following acute myocardial infarction in patients with autoimmune rheumatic disease |
| Q36254129 | Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study |
| Q52312175 | Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. |
| Q35554431 | Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study |
| Q36058974 | Increased prevalence of subclinical atherosclerosis in rheumatoid arthritis patients of Indian descent. |
| Q37060522 | Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction |
| Q89477733 | Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease |
| Q38370895 | Inflammation-induced foam cell formation in chronic inflammatory disease. |
| Q35087941 | Inflammatory bowel disease as a risk factor for premature coronary artery disease |
| Q36677630 | Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis |
| Q46598130 | Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients |
| Q35840716 | Integrated safety in tocilizumab clinical trials |
| Q51652663 | Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial |
| Q36245829 | Interaction between smoking and functional polymorphism in the TGFB1 gene is associated with ischaemic heart disease and myocardial infarction in patients with rheumatoid arthritis: a cross-sectional study |
| Q35582653 | Interpretation of observational studies |
| Q37121264 | Is cumulative exposure to economic hardships more hazardous to women's health than men's? A 16-year follow-up study of the Swedish Survey of Living Conditions |
| Q80051153 | Is rheumatoid arthritis a risk factor for cardiovascular disease? |
| Q33596583 | Knowledge and perception of cardiovascular disease risk among patients with rheumatoid arthritis |
| Q35656020 | Lack of association of oral calcium supplementation with coronary artery calcification in rheumatoid arthritis |
| Q37866668 | Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center |
| Q36007909 | Large artery stiffness and inflammation |
| Q28392474 | Late-Onset Asthma Predicts Cardiovascular Disease Events: The Wisconsin Sleep Cohort |
| Q45265863 | Left ventricular morphology and function in patients with rheumatoid arthritis |
| Q33482833 | Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis |
| Q57658287 | Link between traditional cardiovascular risk factors and inflammation in patients with early arthritis: Results from a French Multicenter Cohort |
| Q33765761 | Lipid and lipoprotein levels and trend in rheumatoid arthritis compared to the general population |
| Q35638659 | Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis |
| Q49721726 | Lipids in RA: Is Less Not Necessarily More? |
| Q47959078 | Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis. |
| Q36182351 | Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis |
| Q34328320 | Longterm outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis. |
| Q92054246 | Low serum IGF1 is associated with hypertension and predicts early cardiovascular events in women with rheumatoid arthritis |
| Q35555347 | Lower limb arterial incompressibility and obstruction in rheumatoid arthritis |
| Q36480668 | Macrophage migration inhibitory factor and glucocorticoid sensitivity. |
| Q37428743 | Management of cardiovascular disease risk in chronic inflammatory disorders |
| Q37173212 | Management of chronic nonmalignant pain with nonsteroidal antiinflammatory drugs. Joint opinion statement of the Ambulatory Care, Cardiology, and Pain and Palliative Care Practice and Research Networks of the American College of Clinical Pharmacy |
| Q36262489 | Management of co-morbidities and general medical conditions in patients with rheumatoid arthritis |
| Q97524590 | Management of multivessel coronary artery disease in patients with non-ST-elevation myocardial infarction: a complex path to precision medicine |
| Q37930978 | Management of psoriatic arthritis from the view of the dermatologist |
| Q34641300 | Management of rheumatoid arthritis: consensus recommendations from the Hong Kong Society of Rheumatology |
| Q37975943 | Managing cardiovascular risk in patients with chronic inflammatory diseases. |
| Q36577423 | Mechanisms of disease: atherosclerosis in autoimmune diseases |
| Q37072381 | Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis |
| Q47929039 | Metabolic abnormalities in rheumatoid arthritis patients with comorbid diabetes mellitus. |
| Q35753545 | Methods to Develop an Electronic Medical Record Phenotype Algorithm to Compare the Risk of Coronary Artery Disease across 3 Chronic Disease Cohorts |
| Q35636960 | Methotrexate modulates the kinetics of adenosine in humans in vivo |
| Q33869938 | Microvascular function is preserved in newly diagnosed rheumatoid arthritis and low systemic inflammatory activity |
| Q42669519 | Modifiable cardiovascular risk factors in Rheumatoid Arthritis |
| Q33629320 | Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapies |
| Q40815110 | Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: |
| Q43013062 | More evidence of declining incidence of amyloidosis associated with inflammatory rheumatic diseases |
| Q34802678 | Muscle wasting associated with pathologic change is a risk factor for the exacerbation of joint swelling in collagen-induced arthritis in cynomolgus monkeys |
| Q24812557 | Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis |
| Q36348370 | NSAID Use and Incident Cognitive Impairment in a Population-based Cohort |
| Q37138669 | New and emerging risk factors for CVD. |
| Q35243557 | No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease |
| Q88347952 | Nocturnal blood pressure dipping is similar in rheumatoid arthritis patients as compared to a normal population |
| Q36964664 | Non-Bacterial Thrombotic Endocarditis in a Patient with Rheumatoid Arthritis |
| Q89424853 | Non-obese visceral adiposity is associated with the risk of atherosclerosis in Japanese patients with rheumatoid arthritis: a cross-sectional study |
| Q37079259 | Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients. |
| Q36327186 | Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? |
| Q36869571 | Nonselective nonsteroidal antiinflammatory drugs and cardiovascular risk: are they safe? |
| Q37710757 | Novel Senescent Regulatory T-Cell Subset with Impaired Suppressive Function in Rheumatoid Arthritis. |
| Q38098935 | Novel risk factors for cardiovascular disease in rheumatoid arthritis |
| Q36879686 | Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review |
| Q34128912 | Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis |
| Q51707940 | Ostial lesions of left main and right coronary arteries: demographic and angiographic features. |
| Q40629689 | Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: an 11-year nationwide cohort study |
| Q24235971 | Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity |
| Q42946041 | Panax notoginseng Saponins Attenuate Atherogenesis Accelerated by Zymosan in Rabbits |
| Q33570509 | Paradoxical association of C-reactive protein with endothelial function in rheumatoid arthritis |
| Q35638493 | Patterns of cardiovascular risk in rheumatoid arthritis |
| Q43450932 | Patterns of preventive health services in rheumatoid arthritis patients compared to a primary care patient population |
| Q37328983 | Perceived and actual risk of cardiovascular disease in patients with rheumatoid arthritis in Korea: A cross-sectional study |
| Q60952997 | Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation |
| Q36235589 | Perioperative all-cause mortality and cardiovascular events in patients with rheumatoid arthritis: comparison with unaffected controls and persons with diabetes mellitus |
| Q35204815 | Physical activity measured by the SenseWear Armband in women with rheumatoid arthritis |
| Q35187101 | Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis |
| Q46682121 | Pleiotropic effects: should statins be considered an essential component in the treatment of dyslipidemia? |
| Q37296393 | Potential role of interleukin-18 in patients with rheumatoid arthritis-associated carotid intima-media thickness but not insulin resistance |
| Q36951050 | Precocious atherosclerosis in rheumatoid arthritis: role of traditional and disease-related cardiovascular risk factors |
| Q44832625 | Predictors of endothelial dysfunction in patients with rheumatoid arthritis |
| Q51572553 | Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks. |
| Q90090165 | Prevalence and associated factors of subclinical atherosclerosis in rheumatoid arthritis at the university hospital of Kinshasa |
| Q44051899 | Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease |
| Q41464826 | Prevalence of Asymptomatic Arterial Hypertension and Its Correlation with Inflammatory Activity in Early Rheumatoid Arthritis. |
| Q47094958 | Prevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals. |
| Q39378053 | Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease |
| Q35622817 | Preventing Cardio-renal Syndrome Rather than Treating It: Could Statins Play A Role? |
| Q38612651 | Prevention of Stroke in Rheumatoid Arthritis |
| Q53502883 | Prevention of stroke in rheumatoid arthritis. |
| Q28196283 | Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors |
| Q38099537 | Pro-inflammatory genetic markers of atherosclerosis. |
| Q36205971 | Proarrhythmic risk and determinants of cardiac autonomic dysfunction in collagen-induced arthritis rats |
| Q38608511 | Progression rate of severity of aortic stenosis in patients with rheumatoid arthritis |
| Q37207171 | Prolong Exposure of NSAID in Patients With RA Will Decrease the Risk of Dementia: A Nationwide Population-Based Cohort Study |
| Q34375590 | Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden |
| Q38365735 | Promoting physical activity in rheumatoid arthritis: a narrative review of behaviour change theories |
| Q36633243 | Prothrombotic effects of tumor necrosis factor alpha in vivo are amplified by the absence of TNF-alpha receptor subtype 1 and require TNF-alpha receptor subtype 2. |
| Q40324538 | Radiographic progression is associated with increased cardiovascular risk in patients with axial spondyloarthritis |
| Q36633235 | Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis |
| Q33792588 | Randomised controlled trial examining the effect of exercise in people with rheumatoid arthritis taking anti-TNFα therapy medication |
| Q36732112 | Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register |
| Q37327034 | Relationship between asymmetric dimethylarginine and endothelial dysfunction in patients with rheumatoid arthritis |
| Q35750211 | Relationship between cyclooxygenase-2 inhibition and thrombogenesis |
| Q50776302 | Relationship of osteoprotegerin to pulse wave velocity and carotid intima-media thickness in rheumatoid arthritis patients. |
| Q33727015 | Rheumatic autoimmune diseases in women and midlife health |
| Q37094851 | Rheumatoid Arthritis and Mortality Among Women During 36 Years of Prospective Follow-Up: Results From the Nurses' Health Study |
| Q99581776 | Rheumatoid Arthritis is Not Associated with Increased Inpatient Mortality in Patients Admitted for Acute Coronary Syndrome |
| Q36001551 | Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative |
| Q37140079 | Rheumatoid arthritis and cardiovascular disease |
| Q36812587 | Rheumatoid arthritis and cardiovascular disease: an update on treatment issues |
| Q54714523 | Rheumatoid arthritis and metabolic syndrome. |
| Q36574986 | Rheumatoid arthritis and the heart |
| Q41936429 | Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment. |
| Q24812262 | Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study |
| Q34346309 | Rheumatoid arthritis patients receive less frequent acute reperfusion and secondary prevention therapy after myocardial infarction compared with the general population |
| Q51181626 | Rheumatoid arthritis prevalence, incidence, and mortality rates: a nationwide population study in Taiwan. |
| Q80975481 | Rheumatoid arthritis, periodontal disease and coronary artery disease |
| Q37774545 | Rheumatoid cachexia and cardiovascular disease. |
| Q36040885 | Rheumatoid disease and the heart: from epidemiology to echocardiography |
| Q34746646 | Rheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts. |
| Q35160608 | Rheumatoid factor, anti-nuclear antibody in ischemic heart disease: Acute versus chronic patients |
| Q92321126 | Rheumatoid nodules in thyroid gland parenchyma as an expression of rheumatoid arthritis: a case report |
| Q36970912 | Rheumatologist and Primary Care Management of Cardiovascular Disease Risk in Rheumatoid Arthritis: Patient and Provider Perspectives. |
| Q35237977 | Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study |
| Q40513822 | Risk of Myocardial Infarction and Stroke in Patients With Granulomatosis With Polyangiitis (Wegener's): A Population-Based Study |
| Q35815364 | Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study |
| Q34348857 | Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis |
| Q36795672 | Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study |
| Q57751622 | Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis |
| Q34206247 | Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden |
| Q34307622 | Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden |
| Q33877737 | Risk of venous thromboembolism in patients with rheumatoid arthritis |
| Q50234923 | Senescent T-Cells Promote Bone Loss in Rheumatoid Arthritis. |
| Q35638369 | Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis |
| Q47671088 | Sex, Symptom Severity, and Quality of Life in Rheumatology |
| Q34363307 | Statin initiation and treatment non-adherence following a first acute myocardial infarction in patients with inflammatory rheumatic disease versus the general population. |
| Q54105644 | Statin therapy in rheumatoid arthritis: a cost-effectiveness and value-of-information analysis. |
| Q37027316 | Statin treatment for rheumatoid arthritis: a promising novel indication |
| Q46158768 | Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes |
| Q40916447 | Subclinical Atherosclerosis in Systemic Sclerosis: Not Less Frequent Than Rheumatoid Arthritis and Not Detected With Cardiovascular Risk Indices |
| Q36968832 | Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus |
| Q41514844 | Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry |
| Q35154761 | Systemic inflammation and early atheroma formation: are they related? |
| Q33923265 | TRAF1/C5 polymorphism is not associated with increased mortality in rheumatoid arthritis: two large longitudinal studies |
| Q41856851 | Tailoring cardiovascular risk assessment and prevention for women: One size does not fit all. |
| Q37689488 | Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins |
| Q37765620 | Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis |
| Q83844887 | Tc-99m sestamibi lower extremity muscle scan, is it a useful screening tool for assessment of preclinical atherosclerosis in rheumatoid arthritis patients? |
| Q41211836 | The 2013 ACC/AHA 10-year atherosclerotic cardiovascular disease risk index is better than SCORE and QRisk II in rheumatoid arthritis: is it enough? |
| Q35739675 | The Crosstalk of Pathways Involved in Immune Response Maybe the Shared Molecular Basis of Rheumatoid Arthritis and Type 2 Diabetes |
| Q64924378 | The Differential Influence of Immunological Process of Autoimmune Disease on Lipid Metabolism: A Study on RA and SLE. |
| Q36504227 | The Risk for Cardiovascular Events Associated with Hyperlipdemia among Patients with and Without Rheumatoid Arthritis |
| Q88576833 | The SLAM family receptors: Potential therapeutic targets for inflammatory and autoimmune diseases |
| Q39218194 | The apoB/apoA1 ratio predicts future cardiovascular events in patients with rheumatoid arthritis |
| Q36790405 | The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study |
| Q49787347 | The association between hydroxychloroquine treatment and cardiovascular morbidity among rheumatoid arthritis patients |
| Q44558171 | The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis |
| Q35135726 | The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis |
| Q89396588 | The best cardiovascular risk calculator to predict carotid plaques in rheumatoid arthritis patients |
| Q36000249 | The challenging interplay between rheumatoid arthritis, ageing and comorbidities |
| Q40900237 | The effects of high intensity interval training in women with rheumatic disease: a pilot study |
| Q35135831 | The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. |
| Q36879940 | The endothelial tyrosine phosphatase SHP-1 plays an important role for vascular haemostasis in TNFα -induced inflammation in vivo |
| Q35092457 | The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. |
| Q35387131 | The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations |
| Q37206876 | The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus |
| Q37173846 | The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis |
| Q35559238 | The multiple facets of premature aging in rheumatoid arthritis |
| Q37457675 | The peroxisome proliferator activated receptor-γ pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis |
| Q38681495 | The potential of food protein-derived anti-inflammatory peptides against various chronic inflammatory diseases. |
| Q43634290 | The relationship between quality of life and aerobic fitness in patients with rheumatoid arthritis |
| Q33892790 | The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study |
| Q37446317 | The risk of atrial fibrillation in patients with rheumatoid arthritis |
| Q43488992 | The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. |
| Q33547329 | The role of endothelial function and its assessment in rheumatoid arthritis. |
| Q36959612 | The role of simvastatin in the therapeutic approach of rheumatoid arthritis |
| Q34713116 | The shared crosstalk of multiple pathways involved in the inflammation between rheumatoid arthritis and coronary artery disease based on a digital gene expression profile |
| Q37817050 | The swollen joint, the thickened artery, and the smoking gun: tobacco exposure, citrullination and rheumatoid arthritis |
| Q35164732 | The therapeutic potential of TNF-alpha blockade in rheumatoid arthritis |
| Q92627208 | The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus |
| Q34897125 | The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28 |
| Q36577503 | Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis |
| Q53021496 | Tissue Doppler imaging in the evaluation of the left and right ventricular diastolic functions in rheumatoid arthritis. |
| Q37859678 | Toll-like receptor signaling: common pathways that drive cardiovascular disease and rheumatoid arthritis |
| Q34109156 | Total calcium-sensing receptor expression in circulating monocytes is increased in rheumatoid arthritis patients with severe coronary artery calcification |
| Q36464352 | Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis |
| Q44293608 | Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis |
| Q36283524 | Tumor necrosis factor-alpha, biologic agents and cardiovascular risk |
| Q64252743 | Tumour Necrosis Factor-α Inhibition Improves Stroke Outcome in a Mouse Model of Rheumatoid Arthritis |
| Q36262479 | Update of TNF-alpha antagonists and cardiovascular disease in rheumatoid arthritis |
| Q43251127 | Vaccination, atherosclerosis and systemic lupus erythematosus |
| Q64086396 | Values and Correlations between C-Reactive Protein and Apolipoprotein B after Treatment with Methotrexate at Patients with Rheumatoid Arthritis |
| Q37630351 | Vascular effects of biologic agents in RA and spondyloarthropathies |
| Q36130959 | Vasculitis: mechanisms involved and clinical manifestations |
| Q46407214 | Which factors are related to the presence of atherosclerosis in rheumatoid arthritis? |
| Q33697879 | Why do people with rheumatoid arthritis still die prematurely? |
| Q81299906 | [Frequency of cardiovascular risk factors and co-morbidity in patients with rheumatic diseases] |
| Q52876178 | [Gender-specific differences in comorbidities of rheumatoid arthritis]. |
| Q87423281 | [Guidelines-oriented diagnostics of dyslipidemia] |
| Q84509548 | [Physical therapy as part of a complex orthopedic rheumatology approach. Physiotherapy, cryotherapy, extracorporeal shockwave lithotripsy, local intra-articular joint injections] |
| Q83048180 | [Systemic manifestations of rheumatoid arthritis] |